Showing results (141-150 of 192) with videos related to
Sort By:
Pageof 20
Blood|May 2, 2013
GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemiaEric Padron, Jeffrey S Painter, Sateesh Kunigal, et al.Leukemia|February 10, 2019
S100A9-induced overexpression of PD-1/PD-L1 contributes to ineffective hematopoiesis in myelodysplastic syndromesPinyang Cheng, Erika A Eksioglu, Xianghong Chen, et al.Blood|June 4, 2014
Aberrant overexpression of CD14 on granulocytes sensitizes the innate immune response in mDia1 heterozygous del(5q) MDSGanesan Keerthivasan, Yang Mei, Baobing Zhao, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2022
Immunodepletion of MDSC by AMV564, a novel bivalent, bispecific CD33/CD3 T cell engager, ex vivo in MDS and melanomaPingyan Cheng, Xianghong Chen, Robert Dalton, et al.Blood|August 24, 2012
Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromesMikkael A Sekeres, Ramon V Tiu, Rami Komrokji, et al.Leukemia Research|March 6, 2012
Seroreactivity to LGL leukemia-specific epitopes in aplastic anemia, myelodysplastic syndrome and paroxysmal nocturnal hemoglobinuria: results of a bone marrow failure consortium studySusan Bell Nyland, Daniel J Krissinger, Michael J Clemente, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Estimating the impact of new clinical trial proven cancer therapy and cancer chemoprevention on population mortality: the Karnofsky Memorial lectureJoseph M Unger, Michael LeBlanc, John J Crowley, et al.Plos One|August 23, 2013
The prognostic significance of IRF8 transcripts in adult patients with acute myeloid leukemiaEra L Pogosova-Agadjanyan, Kenneth J Kopecky, Fabiana Ostronoff, et al.JCI Insight|July 5, 2022
Somatic gene mutations expose cytoplasmic DNA to co-opt the cGAS/STING/NLRP3 axis in myelodysplastic syndromesAmy F McLemore, Hsin-An Hou, Benjamin S Meyer, et al.Clinical Lymphoma, Myeloma & Leukemia|April 19, 2020
Hypomethylating Agent Therapy in Myelodysplastic Syndromes With Chromosome 3 AbnormalitiesDavid A Sallman, John Barnard, Najla H Al Ali, et al.Pageof 20